Steinhubl et al 40 showed that long-term (one-year) clopidogrel therapy significantly reduced the risk of adverse ischemic events in patients who underwent PCI, albeit with a nonsignificant trend of increased bleeding.
1
—
—
Steinhubl et al 40 showed that long-term (one-year) clopidogrel therapy significantly reduced the risk of adverse ischemic events in patients who underwent PCI, albeit with a nonsignificant trend of increased bleeding.